Live Breaking News & Updates on Coronavirus risk associations

Stay informed with the latest breaking news from Coronavirus risk associations on our comprehensive webpage. Get up-to-the-minute updates on local events, politics, business, entertainment, and more. Our dedicated team of journalists delivers timely and reliable news, ensuring you're always in the know. Discover firsthand accounts, expert analysis, and exclusive interviews, all in one convenient destination. Don't miss a beat — visit our webpage for real-time breaking news in Coronavirus risk associations and stay connected to the pulse of your community

Some healthcare workers vaccinated against COVID-19 show unexpectedly low responses to immunizations

A subset of healthcare workers vaccinated against COVID-19 had unexpectedly low responses to the immunizations, according to Cedars-Sinai investigators.

Susan-cheng , Erikaj-glazer , Helen-goodridge , Peter-chen , Emily-henderson , Women-cardiovascular-health , Department-of-cardiology , Pfizer-inc , Institute-for-research-on-healthy , Smidt-heart-institute , Biomedical-sciences , Sinai-board-of-governors-regenerative-medicine-institute

Study: Some Health Care Workers Had Low Response to COVID Vaccine

Some health care workers vaccinated against COVID- 19 had unexpectedly low responses to the immunizations, researchers from Cedars- Sinai Medical Center said Wednesday.

Susan-cheng , Erikaj-glazer , Helen-goodridge , Peter-chen , Women-cardiovascular-health , Pfizer-inc , Cedars-sinai-medical-center , Sinai-board-of-governors-regenerative-medicine-institute , Medical-center , Medallion-chair , Molecular-medicine , Cedars-sinai-board

Study: COVID-19 Survivors Might Only Need One Dose of Two-Dose Vaccine

By City News Service
Apr 1, 2021
LOS ANGELES (CNS) - A single dose of the Pfizer-BioNTech vaccine for people who have already had COVID-19 generates an immunologic response similar to that in people who receive the two-dose recommended sequence, according to a study released today by researchers at Cedars-Sinai.
The study suggests that the second dose may not be needed for people who have successfully recovered from a prior coronavirus infection, according to Dr. Susan Cheng, an associate professor of cardiology and director of Public Health Research at the Smidt Heart Institute at Cedars-Sinai.
“Our findings extend those from smaller studies reported elsewhere and support a potential strategy of providing a single dose of vaccine to persons with a confirmed prior history of coronavirus infection, along with two doses for people not previously infected," Cheng said. “This approach could maximize the reach of a limited vaccine supply, allowing potentially millions more people to be vaccinated in the U.S. alone."

California , United-states , Susan-cheng , Kimia-sobhani , Pfizer , Public-health-research , Sinai-health-system , Smidt-heart-institute-at-cedars , Smidt-heart-institute , Cedars-sinai-health-system , Coronavirus-risk-associations , Longitudinal-evaluation